JOSE LUIS
MAURIZ GUTIÉRREZ
Profesor Titular de Universidad
TANIA
PAYO SERAFÍN
Contrato Predoctoral AECC
TANIA PAYO SERAFÍN-rekin lankidetzan egindako argitalpenak (6)
2024
-
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Clinical Pharmacology and Therapeutics, Vol. 116, Núm. 2, pp. 328-345
2023
-
Hepatocellular carcinoma cells loss lenvatinib efficacy in vitro through autophagy and hypoxia response-derived neuropilin-1 degradation
Acta Pharmacologica Sinica, Vol. 44, Núm. 5, pp. 1066-1082
-
Neuropilins as potential biomarkers in hepatocel-lular carcinoma: a systematic review of basic and clinical implications
Clinical and Molecular Hepatology, Vol. 29, Núm. 2, pp. 293-319
2022
2021
-
Association of foxo3 expression with tumor pathogenesis, prognosis and clinicopathological features in hepatocellular carcinoma: A systematic review with meta-analysis
Cancers, Vol. 13, Núm. 21
-
Autophagy-related chemoprotection against sorafenib in human hepatocarcinoma: Role of foxo3 upregulation and modulation by regorafenib
International Journal of Molecular Sciences, Vol. 22, Núm. 21